Literature DB >> 16736

Interactions with antiepileptic drugs.

A Richens.   

Abstract

Most of the currently available antiepileptic drugs have a low therapeutic ratio and therefore a drug interaction causing elevation of the serum level of one of these compounds can readily lead to drug intoxication. Phenytoin, in particular, is vulnerable because its metabolism is dose-related and at therapeutic serum levels the enzyme system involved in its degradation is easily inhibited by concurrent drug administration. As multiple drug therapy has traditionally been practised in the management of epilepsy, clinically important interactions are common. Furthermore, most of the drugs used in the treatment of major epilepsies are potent inducers of hepatic microsomal enzymes and can therefore stimulate the metabolism of concurrently-administered drugs to such an extent that they may be rendered ineffective. The use of one drug alone is recommended, where possible, in the management of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16736     DOI: 10.2165/00003495-197713040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  50 in total

1.  Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.

Authors:  A W Meikle; W Jubiz; S Matsukura; C D West; F H Tyler
Journal:  J Clin Endocrinol Metab       Date:  1969-12       Impact factor: 5.958

2.  Effect of diphenylhydantoin on the metabolism of dicoumarol in man.

Authors:  J M Hansen; K Siersbaek-Nielsen; M Kristensen; L Skovsted; L K Christensen
Journal:  Acta Med Scand       Date:  1971 Jan-Feb

3.  Preliminary observations of serum carbamazepine concentration in epileptic patients.

Authors:  J J Cereghino; J C Meter; J T Brock; J K Penry; L D Smith; B G White
Journal:  Neurology       Date:  1973-04       Impact factor: 9.910

4.  The effect of phenyramidol on the metabolism of diphenylhydantoin.

Authors:  H M Solomon; J J Schrogie
Journal:  Clin Pharmacol Ther       Date:  1967 Jul-Aug       Impact factor: 6.875

5.  Acute diphenylhydantoin intoxication following halothane anesthesia.

Authors:  J M Karlin; H Kutt
Journal:  J Pediatr       Date:  1970-06       Impact factor: 4.406

6.  Controlled trial of sodium valproate in severe epilepsy.

Authors:  A Richens; S Ahmad
Journal:  Br Med J       Date:  1975-11-01

7.  Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.

Authors:  O Sjö; E F Hvidberg; J Naestoft; M Lund
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

8.  Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.

Authors:  H Kutt; W Winters; F H McDowell
Journal:  Neurology       Date:  1966-06       Impact factor: 9.910

Review 9.  Ethanol metabolism and ethanol-drug interactions.

Authors:  E Mezey
Journal:  Biochem Pharmacol       Date:  1976-04-15       Impact factor: 5.858

10.  Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications.

Authors:  E Hempel; W Klinger
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

View more
  12 in total

1.  A comparison of carbamazepine divitabs with carbamazepine normal formulation in psychiatric and oligophrenic patients. Preliminary pharmacokinetic results.

Authors:  A J Loonen; P J Toll; J R Nijdam
Journal:  Pharm Weekbl Sci       Date:  1989-02-24

2.  Lack of hepatic enzyme inducing effect of sodium valproate.

Authors:  J Oxley; A Hedges; K A Makki; A Monks; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

Review 3.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

4.  Interaction between phenytoin and antacids.

Authors:  V K Kulshrestha; M Thomas; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

5.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

Review 6.  The risk-benefit ratio of anticonvulsant drugs.

Authors:  M J Eadie
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 7.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors:  A Monks; S Boobis; J Wadsworth; A Richens
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.